Uncovering direct targets of MiR-19a involved in lung cancer progression

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Yamamoto, Kumiko ^a   Ito, Sachio ^a   Hanafusa, Hiroko ^a   Shimizu, Kenji ^a   Ouchida, Mamoru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGONAUTE 2 PROTEIN; LOCKED NUCLEIC ACID; MICRORNA; PROTEIN FOXP1; PROTEIN MIR 19A; PROTEIN TNFAIP3; PROTEIN TP53INP1; PROTEIN TUSC2; TRANSCRIPTION FACTOR; TUMOR PROTEIN; UNCLASSIFIED DRUG; MIRN19 MICRORNA, HUMAN; RNA;

A549 CELL LINE; ARTICLE; BINDING SITE; BIOTINYLATION; CELL INVASION ASSAY; CELL MIGRATION; CELL VIABILITY; COLONY FORMATION; COMPUTER PROGRAM; EMBRYO; EXPRESSION VECTOR; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENETIC SELECTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LUNG CANCER; LUNG CARCINOGENESIS; PLASMID; PROTEIN BINDING; WESTERN BLOTTING; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LUNG TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM PROTEINS; RNA, NEOPLASM;

EID: 84947554482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137887     Document Type: Article

References (49)

1. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006 Oct; 11(4): 441-450. PMID: 17011485
2. Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004 Oct 13; 23(20): 4051-4060. PMID: 15372072
3. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell. 2004 Jan 23; 116(2): 281-297. PMID: 14744438
4. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005 May; 6 (5): 376-385. PMID: 15852042
5. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003 Sep 25; 425(6956): 415-419. PMID: 14508493
6. Yoda M, Kawamata T, Paroo Z, Ye X, Iwasaki S, Liu Q, et al. ATP-dependent human RISC assembly pathways. Nat Struct Mol Biol. 2010 Jan; 17(1): 17-23. doi: 10.1038/nsmb.1733 PMID: 19966796
7. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, et al. Argonaute2 is the catalytic engine of mammalian RNAi. Science. 2004 Sep 3; 305(5689): 1437-1441. PMID: 15284456
8. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell. 2004 Jul 23; 15(2): 185-197. PMID: 15260970
9. Tomari Y, Du T, Zamore PD. Sorting of Drosophila small silencing RNAs. Cell. 2007 Jul 27; 130(2): 299-308. PMID: 17662944
10. Kawamata T, Seitz H, Tomari Y. Structural determinants of miRNAs for RISC loading and slicer-independent unwinding. Nat Struct Mol Biol. 2009 Sep; 16(9): 953-960. doi: 10.1038/nsmb.1630 PMID: 19684602
11. Azuma-Mukai A, Oguri H, Mituyama T, Qian ZR, Asai K, Siomi H, et al. Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc Natl Acad Sci USA. 2008 Jun 10; 105(23): 7964-7969. doi: 10.1073/pnas.0800334105 PMID: 18524951
12. Su H, Trombly MI, Chen J, Wang X. Essential and overlapping functions for mammalian argonautes in microRNA silencing. Genes Dev. 2009 Feb 1; 23(3): 304-317. doi: 10.1101/gad.1749809 PMID: 19174539
13. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005 Jan 14; 120(1): 15-20. PMID: 15652477
14. Langevin SM, Kratzke RA, Kelsey KT. Epigenetics of lung cancer. Transl Res. 2015 Jan; 165(1): 74-90. doi: 10.1016/j.trsl.2014.03.001 PMID: 24686037
15. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, et al. A polycistronic micro-RNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005 Nov 1; 65(21): 9628-9632. PMID: 16266980
16. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005 Jun 9; 435(7043): 828-833. PMID: 15944707
17. Mogilyansky E, Rigoutsos I. The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ. 2013 Dec; 20(12): 1603-1614. doi: 10.1038/cdd.2013.125 PMID: 24212931
18. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, et al. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 2009 Dec 15; 23(24): 2839-2849. doi: 10.1101/gad.1861409 PMID: 20008935
19. Mu P, Han YC, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17-92 cluster of microRNAs in Myc-induced B-cell lymphomas. Genes Dev. 2009 Dec 15; 23(24): 2806-2811. doi: 10.1101/gad.1872909 PMID: 20008931
20. Hackl M, Brunner S, Fortschegger K, Schreiner C, Micutkova L, Mück C, et al. miR-17, miR-19b, miR- 20a, and miR-106a are down-regulated in human aging. Aging Cell. 2010 Apr; 9(2): 291-296. doi: 10.1111/j.1474-9726.2010.00549.x PMID: 20089119
21. Van Almen GC, Verhesen W, van Leeuwen REW, van de Vrie M, Eurlings C, Schellings MWM, et al. MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging Cell. 2011 Oct; 10(5): 769-779. doi: 10.1111/j.1474-9726.2011.00714.x PMID: 21501375
22. Ouchida M, Kanzaki H, Ito S, Hanafusa H, Jitsumori Y, Tamaru S, et al. Novel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approach. PLoS ONE. 2012; 7(8): e44095. doi: 10.1371/journal.pone.0044095 PMID: 22952885
23. Liu M, Wang Z, Yang S, Zhang W, He S, Hu C, et al. TNF-α is a novel target of miR-19a. Int J Oncol. 2011 Apr; 38(4): 1013-1022. doi: 10.3892/ijo.2011.924 PMID: 21271217
24. Kanzaki H, Ito S, Hanafusa H, Jitsumori Y, Tamaru S, Shimizu K, et al. Identification of direct targets for the miR-17-92 cluster by proteomic analysis. Proteomics. 2011 Sep; 11(17): 3531-3539. doi: 10.1002/pmic.201000501 PMID: 21751348
25. Nonne N, Ameyar-Zazoua M, Souidi M, Harel-Bellan A. Tandem affinity purification of miRNA target mRNAs (TAP-Tar). Nucleic Acids Res. 2010 Mar; 38(4): e20. doi: 10.1093/nar/gkp1100 PMID: 19955234
26. Lu W, Xu Z, Zhang M, Zuo Y. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer. Int J Clin Exp Pathol. 2014 Sep 15; 7(10): 7286-7296. PMID: 25400827
27. Hao M, Zang M, Wendlandt E, Xu Y, An G, Gong D, et al. Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma. Int J Cancer. 2015 Apr 15; 136(8): 1835-1844. doi: 10.1002/ijc.29199 PMID: 25220540
28. Zhong J, He Y, Chen W, Shui X, Chen C, Lei W. Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int J Mol Sci. 2014 Nov 6; 15(11): 20355-20364. doi: 10.3390/ijms151120355 PMID: 25383678
29. Bonapace L, Coissieux MM, Wyckoff J, Mertz KD, Varga Z, Junt T, et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis. Nature. 2014 Nov 6; 515(7525): 130-133. doi: 10.1038/nature13862 PMID: 25337873
30. Asai H, Fujiwara H, An J, Ochi T, Miyazaki Y, Nagai K, et al. Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor. PLoS ONE. 2013; 8(2): e56820. doi: 10.1371/journal.pone.0056820 PMID: 23441216
31. Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. Cancer Res. 2000 Nov 1; 60(21): 6116-6133. PMID: 11085536
32. Rutnam ZJ, Du WW, Yang W, Yang X, Yang BB. The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs. Nat Commun. 2014; 5: 2914. doi: 10.1038/ncomms3914 PMID: 24394498
33. Lin J, Xu K, Gitanjali J, Roth JA, Ji L. Regulation of tumor suppressor gene FUS1 expression by the untranslated regions of mRNA in human lung cancer cells. Biochem Biophys Res Commun. 2011 Jul 1; 410(2): 235-241. doi: 10.1016/j.bbrc.2011.05.122 PMID: 21645495
34. Prudkin L, Behrens C, Liu DD, Zhou X, Ozburn NC, Bekele BN, et al. Loss and reduction of Fus1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer. Clin Cancer Res. 2008 Jan 1; 14(1): 41-47. doi: 10.1158/1078-0432.CCR-07-1252 PMID: 18172250
35. Meng J, Majidi M, Fang B, Ji L, Bekele BN, Minna JD, et al. The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner. PLoS ONE. 2013 Oct 17; 8(10): e77067. doi: 10.1371/journal.pone.0077067 PMID: 24146957
36. Lu C, Stewart DJ, Lee JJ, Ji L, Ramesh R, Jayachandran G, et al. Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS ONE. 2012; 7(4): e34833. doi: 10.1371/journal.pone.0034833 PMID: 22558101
37. Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, Croce KJ, et al. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood. 2008 Dec 1; 112(12): 4699-4711. doi: 10.1182/blood-2008-01-137018 PMID: 18799727
38. Ackermann S, Kocak H, Hero B, Ehemann V, Kahlert Y, Oberthuer A, et al. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma. BMC Cancer. 2014 Nov 18; 14: 840. doi: 10.1186/1471-2407-14-840 PMID: 25406647
39. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002 Oct 7; 21(45): 6915-6935. PMID: 12362274
40. Takayama K, Suzuki T, Tsutsumi S, Fujimura T, Takahashi S, Homma Y, et al. Integrative analysis of FOXP1 function reveals a tumor-suppressive effect in prostate cancer. Mol Endocrinol. 2014 Dec; 28 (12): 2012-2024. doi: 10.1210/me.2014-1171 PMID: 25329375
41. Okamura S, Arakawa H, Tanaka T, Nakanishi H, Ng CC, Taya Y, et al. p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell. 2001 Jul; 8(1): 85-94. PMID: 11511362
42. Qin J, Luo M, Qian H, Chen W. Upregulated miR-182 increases drug resistance in cisplatin-treated HCC cell by regulating TP53INP1. Gene. 2014 Apr 1; 538(2): 342-347. doi: 10.1016/j.gene.2013.12. 043 PMID: 24447717
43. Zhang J, Cheng C, Yuan X, He JT, Pan QH, Sun FY. microRNA-155 acts as an oncogene by targeting the tumor protein 53-induced nuclear protein 1 in esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 2014 Jan 15; 7(2): 602-610. PMID: 24551280
44. Liu F, Kong X, Lv L, Gao J. MiR-155 targets TP53INP1 to regulate liver cancer stem cell acquisition and self-renewal. FEBS Lett. 2015 Feb 13; 589(4): 500-506. doi: 10.1016/j.febslet.2015.01.009 PMID: 25601564
45. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: An absolute requirement for transcription factor NF-κB. FEBS Lett. 1998 Sep 11; 435(1): 29-34. PMID: 9755853
46. Kanayama M, Inoue M, Danzaki K, Hammer G, He YW, Shinohara ML. Autophagy enhances NFκB activity in specific tissue macrophages by sequestering A20 to boost antifungal immunity. Nat Commun. 2015 Jan 22; 6: 5779. doi: 10.1038/ncomms6779 PMID: 25609235
47. Wertz IE, O'Rourke KM, Zhou H, Eby M, Aravind L, Seshagiri S, et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signaling. Nature. 2004 Aug 5; 430(7000): 694-699. PMID: 15258597
48. Song HY, Rothe M, Goeddel DV. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc Natl Acad Sci USA. 1996 Jun 25; 93(13): 6721-6725. PMID: 8692885
49. Heyninck K, De Valck D, Vanden Berghe W, Van Criekinge W, Contreras R, Fiers W, et al. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN. J Cell Biol. 1999 Jun 28; 145(7): 1471-1482. PMID: 10385526